Correlation Between Embrace Change and Oncologix Tech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Embrace Change and Oncologix Tech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Embrace Change and Oncologix Tech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Embrace Change Acquisition and Oncologix Tech, you can compare the effects of market volatilities on Embrace Change and Oncologix Tech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Embrace Change with a short position of Oncologix Tech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Embrace Change and Oncologix Tech.

Diversification Opportunities for Embrace Change and Oncologix Tech

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Embrace and Oncologix is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Embrace Change Acquisition and Oncologix Tech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Oncologix Tech and Embrace Change is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Embrace Change Acquisition are associated (or correlated) with Oncologix Tech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Oncologix Tech has no effect on the direction of Embrace Change i.e., Embrace Change and Oncologix Tech go up and down completely randomly.

Pair Corralation between Embrace Change and Oncologix Tech

If you would invest  1,151  in Embrace Change Acquisition on September 12, 2024 and sell it today you would earn a total of  9.00  from holding Embrace Change Acquisition or generate 0.78% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy98.44%
ValuesDaily Returns

Embrace Change Acquisition  vs.  Oncologix Tech

 Performance 
       Timeline  
Embrace Change Acqui 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Embrace Change Acquisition are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite nearly stable fundamental indicators, Embrace Change is not utilizing all of its potentials. The latest stock price disturbance, may contribute to mid-run losses for the stockholders.
Oncologix Tech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Oncologix Tech has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable essential indicators, Oncologix Tech is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Embrace Change and Oncologix Tech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Embrace Change and Oncologix Tech

The main advantage of trading using opposite Embrace Change and Oncologix Tech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Embrace Change position performs unexpectedly, Oncologix Tech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oncologix Tech will offset losses from the drop in Oncologix Tech's long position.
The idea behind Embrace Change Acquisition and Oncologix Tech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Other Complementary Tools

Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Technical Analysis
Check basic technical indicators and analysis based on most latest market data